Cultivation of an adaptive domestic network for surveillance and evaluation of emerging infections

Emerging Infectious Diseases

Volumn 21, Issue 9, 2015, Pages 1499-1509

  Pinner, Robert W ^a   Lynfield, Ruth ^b   Hadler, James L ^c   Schaffner, William ^d   Farley, Monica M ^e   Frank, Mark E ^a   Schuchat, Anne ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MINNESOTA DEPARTMENT OF HEALTH   (United States)

^c YALE UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CREUTZFELDT JAKOB DISEASE; DISEASE SURVEILLANCE; ENTEROBACTERIACEAE INFECTION; FOOD POISONING; FUNGAL MENINGITIS; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTHCARE ASSOCIATED INFECTION; HOSPITALIZATION; HUMAN; INFLUENZA A (H1N1); PAPILLOMAVIRUS INFECTION; PNEUMOCOCCAL INFECTION; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; STREPTOCOCCUS INFECTION; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; HEALTH SURVEY; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; UNITED STATES;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; HUMANS; MODELS, ORGANIZATIONAL; PUBLIC HEALTH SURVEILLANCE; UNITED STATES;

EID: 84939530153     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2109.150619     Document Type: Article

References (39)

1. Institute of Medicine. Emerging infections: microbial threats to health in the United States. Washington (DC): National Academy Press; 1992 [cited 2015 Jun 18]. http://www.nap.edu/catalog/2008/emerging-infections-microbial-threats-to-health-in-the-united-states.
2. Centers for Disease Control and Prevention. Addressing emerging infectious disease threats: a prevention strategy for the United States; 1994 [cited 2015 Jun 18]. ftp://ftp.cdc.gov/pub/infectious_diseases/emergplan/pdf/emergplan.pdf.
3. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis. 1990;162:1316-23. http://dx.doi.org/10.1093/infdis/162.6.1316
4. Schuchat A, Deaver KA, Wenger JD, Plikaytis BD, Mascola L, Pinner RW, et al. Role of foods in sporadic listeriosis. I. Case-control study of dietary risk factors. The Listeria Study Group. JAMA. 1992;267:2041-5. http://dx.doi.org/10.1001/jama.1992.03480150047035
5. Pinner RW, Gellin BG, Bibb WF, Baker CN, Weaver R, Hunter SB, et al. Meningococcal disease in the United States-1986. Meningococcal Disease Study Group. J Infect Dis. 1991;164:368-74. http://dx.doi.org/10.1093/infdis/164.2.368
6. Reingold AL, Broome CV, Gaventa S, Hightower AW. Risk factors for menstrual toxic shock syndrome: results of a multistate case-control study. Review of Infectious Diseases. 1989;11 Suppl 1:S35-41; discussion S41-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1906910&dopt=Abstract
7. Fraser DW, Geil CC, Feldman RA. Bacterial meningitis in Bernalillo County, New Mexico: a comparison with three other American populations. Am J Epidemiol. 1974;100:29-34.
8. Pinner RW, Rebmann CA, Schuchat A, Hughes JM. Disease surveillance and the academic, clinical, and public health communities. Emerg Infect Dis. 2003;9:781-7. http://dx.doi.org/ 10.3201/eid0907.030083
9. Hadler J, Danila RN, Cieslak PR, Meek JI, Schaffner W, Smith KE, et al. Emerging infections programs-state health department perspective. Emerg Infect Dis. 2015;21:1510-1515.
10. Langley G, Schaffner W, Farley MM, Lynfield R, Bennett NM, Reingold A, et al. Twenty years of Active Bacterial Core Surveillance. Emerg Infect Dis. 2015;21:1520-1528.
11. Skoff T, Baumbach J, Cieslak PR. Tracking pertussis and evaluating control measures through enhanced pertussis surveillance, Emerging Infections Program, United States. Emerg Infect Dis. 2015;21:1568-1573.
12. Henao OL, Jones TF, Vugia DJ, Griffin PM. Foodborne Diseases Active Surveillance Network-2 decades of achievements, 1996-2015. Emerg Infect Dis. 2015;21:1529-1536.
13. Chaves SS, Lynfield R, Lindegren ML, Bresee J, Finelli L. The US influenza hospitalization surveillance network. Emerg Infect Dis. 2015;21:1543-1550.
14. Magill SS, Dumyati G, Ray SM, Fridkin SK. Evaluating epidemiology and improving surveillance of infections associated with health care, United States. Emerg Infect Dis. 2015;21:1537-1542.
15. Klevens RM, Miller JT, Iqbal K, Thomas A, Rizzo EM, Hanson H, et al. The evolving epidemiology of hepatitis a in the United States: incidence and molecular epidemiology from population-based surveillance, 2005-2007. Arch Intern Med. 2010;170:1811-8. http://dx.doi.org/10.1001/archinternmed.2010.401
16. Hajjeh RA, Relman D, Cieslak PR, Sofair AN, Passaro D, Flood J, et al. Surveillance for unexplained deaths and critical illnesses due to possibly infectious causes, United States, 1995-1998. Emerg Infect Dis. 2002;8:145-53. http://dx.doi.org/10.3201/eid0802.010165
17. Bloch KC, Glaser CA. Encephalitis surveillance through the Emerging Infections Program, 1997-2010. Emerg Infect Dis. 2015; 21:1562-1567.
18. Hariri S, Markowitz LE, Bennett NM, Niccolai LM, Schafer S, Bloch KC, et al. Monitoring effect of human papillomavirus vaccines in US population, Emerging Infections Program, 2008-2012. Emerg Infect Dis. 2015;21:1557-1561.
19. Centers for Disease Control and Prevention. Surveillance for Creutzfeldt-Jakob disease-United States. MMWR Morb Mortal Wkly Rep. 1996;45:665-8.
20. Thomas JD, Jackson ML, Sharma D, Mair R, Bach MC, Castillo D, et al. Haemophilus influenzae type b carriage among young children in metropolitan Atlanta in the context of vaccine shortage and booster dose deferral. Clin Vaccine Immunol. 2011;18:2178-80. http://dx.doi.org/10.1128/CVI.05254-11
21. Lowther SA, Shinoda N, Juni BA, Theodore MJ, Wang X, Jawahir SL, et al. Haemophilus influenzae type b infection, vaccination, and H. influenzae carriage in children in Minnesota, 2008-2009. Epidemiol Infect. 2012;140:566-74. http://dx.doi.org/ 10.1017/S0950268811000793
22. Wise ME, Viray M, Sejvar JJ, Lewis P, Baughman AL, Connor W, et al. Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Am J Epidemiol. 2012;175:1110-9. http://dx.doi.org/10.1093/aje/kws196
23. Kainer MA, Reagan DR, Nguyen DB, Wiese AD, Wise ME, Ward J, et al. Fungal infections associated with contaminated methylprednisolone in Tennessee. N Engl J Med. 2012;367:2194-203. http://dx.doi.org/10.1056/NEJMoa1212972
24. Centers for Disease Control and Prevention. Multistate outbreak of fungal meningitis and other infections [cited 2015 June 18]. http://www.cdc.gov/hai/outbreaks/meningitis.html
25. Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000;49:1-35.
26. Nuorti JP, Whitney CG; Centers for Disease Control and Prevention. Prevention of pneumococcal disease among infants and children-use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59:1-18.
27. Dale JB, Penfound TA, Tamboura B, Sow SO, Nataro JP, Tapia M, et al. Potential coverage of a multivalent M protein-based group A streptococcal vaccine. Vaccine. 2013;31:1576-81. http://dx.doi.org/ 10.1016/j.vaccine.2013.01.019
28. Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62:1-28.
29. Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH, et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. N Engl J Med. 1999;340:1525-32. http://dx.doi.org/10.1056/NEJM199905203402001
30. Fridkin SK, Cleveland AA, See I, Lynfield R. Emerging Infections Program as antimicrobial drug resistance surveillance. Emerg Infect Dis. 2015;21:1578-1581.
31. Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015;15:301-9. http://dx.doi.org/10.1016/S1473-3099(14)71081-3
32. Hicks LA, Chien YW, Taylor TH Jr, Haber M, Klugman KP; Active Bacterial Core Surveillance Team. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. Clin Infect Dis. 2011;53:631-9. http://dx.doi.org/10.1093/cid/cir443
33. Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA. 2010;304:641-8. http://dx.doi.org/10.1001/jama.2010.1115
34. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:825-34. http://dx.doi.org/ 10.1056/NEJMoa1408913
35. Chea N, Bulens SN, Kongphet TT, Lynfield R, Shaw KM, Snippes PM, et al. Improved phenotypic-based definition for identifying carbapenemase producers among carbapenem-resistant Enterobacteriaceae. Emerg Infect Dis. 2015;21:1611-1616.
36. Vugia DJ, Meek JI, Danila RN, Jones TF, Schaffner W, Baumbach J, et al. Training in infectious disease epidemiology through the Emerging Infections Program sites. Emerg Infect Dis. 2015;21:1516-1519.
37. Deutscher M, Beneden CV, Burton D, Shultz A, Morgan OW, Chamany S, et al. Putting surveillance data into context: the role of health care utilization surveys in understanding population burden of pneumonia in developing countries. J Epidemiol Glob Health. 2012;2:73-81. http://dx.doi.org/10.1016/j.jegh.2012.03.001
38. Langley G, Besser J, Iwamoto M, Lessa FC, Cronquist A, Skoff TH, et al. Effect of culture-independent diagnostic tests on future Emerging Infections Program surveillance. Emerg Infect Dis.2015;21:1582-1588.
39. Marks JS. Epidemiology, public health, and public policy. Prev Chronic Dis. 2009;6:A134.